C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/4709 (2006.01) A61K 31/55 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 19/02 (2006.01) C07D 215/42 (2006.01) C07D 401/14 (2006.01) C07D 413/04 (2006.01) C07D 491/10 (2006.01)
Patent
CA 2446324
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, R4, R5 and A have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
L'invention concerne des composés de formule (I), ainsi que leurs sels et esters pharmaceutiquement acceptables, dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿ et A ont les significations spécifiées dans la revendication 1. Ces composés peuvent être utilisés, sous la forme de préparations pharmaceutiques, pour le traitement ou la prévention de l'arthrite, de maladies cardiovasculaires, du diabète, d'insuffisances rénales, de dérèglements alimentaires et de l'obésité.
Mueller Werner
Neidhart Werner
Pflieger Philippe
Plancher Jean-Marc
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Quinoline derivatives as ligands for the neuropeptide y... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as ligands for the neuropeptide y..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as ligands for the neuropeptide y... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1370517